This article contains some figures that are displayed in color online but in black-and-white in the print edition.
Battle TEWierda WGRassenti LZZahrieh DNeuberg DKipps TJ: In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response. Clin Cancer Res 9:2166–21722003
Marinaro JANeumann GMRusso VCLeeding KSBach LA: O-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis. Eur J Biochem 267:5378–53862000
Natsuizaka MOhashi SWong GSAhmadi AKalman RABudo D: Insulin-like growth factor-binding protein-3 promotes transforming growth factor-beta1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells. Carcinogenesis 31:1344–13532010
Oh SHLee OHSchroeder CPOh YWKe SCha HJ: Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition. Mol Cancer Ther 5:2685–26952006
Santosh VArivazhagan ASreekanthreddy PSrinivasan HThota BSrividya MR: Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma. Cancer Epidemiol Biomarkers Prev 19:1399–14082010
Sivaprasad UFleming JVerma PSHogan KADesury GCohick WS: Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells. Endocrinology 145:4213–42212004